Skip to main content
Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact
  • IFU
  • Secure area
  • Global
  • United States
Open/Close
  • Search
  • Contact us
  • +32 15 632 600
  • Subscribe to news
  • Global
  • United States

Idylla IDH1-2 Mutation Assay Kit - Innovative. Fast. Easy.

HepatoPredict - A prognostic tool to support liver transplantation in patients with hepatocellular carcinoma.

Merlin™ Assay CE-IVD - Helps identify melanoma patients who have a low risk for nodal metastasis.

Study demonstrates Idylla EGFR Mutation Test shortens time to patient management decisions for NSCLC patients

Study shows Rapid Idylla EGFR Testing Alongside NGS Has Potential to Enhance Lung Cancer Patient Health Outcomes.

Oncology Tests van Biocartis

Oncology In Vitro Diagnostic Tests

Biocartis offers IVD tests for colorectal cancer, melanoma and lung cancer

  1. Home
  2. Meet Idylla
  3. Oncology In Vitro Diagnostic Tests
Menu
  • Meet Idylla
    • Idylla Platform
    • Oncology Tests
    • Publications
  • Oncology
    • Oncology Tests
    • Oncologist
    • Pathologist
    • On-Demand Webinars
  • Oncology Research
    • Research Assays
    • IIS Information
    • On-Demand Webinars
  • Partnering
    • Content Partnering
    • Pharma Partnering
    • Partnering Contact
    • Global Commercialization
  • Press & Events
    • Press Releases
    • Events
  • About Us
    • Team
    • Our Distributors
    • Careers
    • Download Center
    • Contact

Oncology In vitro diagnostic tests

Idylla EGFR Mutation Test

Fully automated detection of 51 EGFR mutations, directly from 1 FFPE tissue section from patients with mNSCLC.

Lung Cancer
Solid
Read more

Idylla GeneFusion Panel

Fully automated detection of ALK, ROS1 and RET fusions & MET exon 14 skipping, directly from 1 FFPE tissue section from patients with NSCLC.

Lung Cancer
Solid
Read more

Idylla BRAF Mutation Test

Fully automated detection of 7 BRAF mutations, directly from 1 FFPE tissue section from patients with metastatic melanoma.

Melanoma
Solid
Read more

Idylla KRAS Mutation Test

Fully automated detection of 21 KRAS mutations, directly from 1 FFPE tissue section from patients with mCRC.

Colorectal Cancer
Solid
Read more

Idylla NRAS-BRAF Mutation Test

Fully automated detection of 18 NRAS mutations and 5 BRAF mutations, directly from 1 FFPE tissue section from patients with mCRC.

Colorectal Cancer
Solid
Read more

Idylla MSI Test

Fully automated detection 7 monomorphic biomarkers, directly from 1 FFPE tissue section from patients with CRC.

Colorectal Cancer
Solid
Read more
  • Meet Idylla
  • Oncology
  • Oncology Research
  • Partnering
  • Press & Events
  • About Us

Biocartis NV

Generaal De Wittelaan 11B

2800 Mechelen, Belgium

Phone: +32 15 632 600

[email protected]

 

Biocartis US

  • Subscribe to news
  • Contact us
  • Request demo
  • Download center
  • LinkedIn
  • Facebook
  • YouTube
  • Twitter
  • Cookie policy
  • Privacy policy
  • Terms of use
© 2025 Biocartis Created by O2 Agency